These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24333304)

  • 1. Plasma and plasma-derived medicinal product self-sufficiency: the Italian case.
    Calizzani G; Profili S; Candura F; Lanzoni M; Vaglio S; Cannata L; Catalano L; Chianese R; Liumbruno GM; Grazzini G
    Blood Transfus; 2013 Sep; 11 Suppl 4(Suppl 4):s118-31. PubMed ID: 24333304
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma-derived medicinal products self-sufficiency from national plasma: to what extent?
    De Angelis V; Breda A
    Blood Transfus; 2013 Sep; 11 Suppl 4(Suppl 4):s132-7. PubMed ID: 24333306
    [No Abstract]   [Full Text] [Related]  

  • 3. Sustainability of a public system for plasma collection, contract fractionation and plasma-derived medicinal product manufacturing.
    Grazzini G; Ceccarelli A; Calteri D; Catalano L; Calizzani G; Cicchetti A
    Blood Transfus; 2013 Sep; 11 Suppl 4(Suppl 4):s138-47. PubMed ID: 24333307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Italy cracks down on its drugs bill.
    Turone F
    BMJ; 2002 Nov; 325(7372):1058. PubMed ID: 12428609
    [No Abstract]   [Full Text] [Related]  

  • 5. [Perfection of structure of purchase of medicinal agents in medical service of the Armed Forces].
    Belevitin AB; Miroshnichenko IuV; Goriachev AB; Krasavin KD
    Voen Med Zh; 2010 Mar; 331(3):4-10. PubMed ID: 20536054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Dublin Consensus Statement 2012 on optimised supply of plasma-derived medicinal products.
    O'Mahony B
    Blood Transfus; 2013 Oct; 11(4):623-6. PubMed ID: 24120590
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma-derived industry and plasma-derived medicinal products in the Italian National Blood Transfusion Service.
    De Silvestro G; Marson P; Breda A; De Angelis V
    Transfus Apher Sci; 2019 Oct; 58(5):545-549. PubMed ID: 31431349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collective pharmaceutical procurement in China may have unintended consequences in supply and pricing.
    Jiang S; Chen Z; Wu T; Wang H
    J Glob Health; 2020 Jun; 10(1):010314. PubMed ID: 32566150
    [No Abstract]   [Full Text] [Related]  

  • 9. The road to recovery.
    Morel CM; Carvalheiro JR; Romero CN; Costa EA; Buss PM
    Nature; 2007 Sep; 449(7159):180-2. PubMed ID: 17851516
    [No Abstract]   [Full Text] [Related]  

  • 10. Russia's prescription drugs crisis.
    Parfitt T
    Lancet; 2007 May; 369(9575):1779-80. PubMed ID: 17536237
    [No Abstract]   [Full Text] [Related]  

  • 11. Medicare holds lottery for access to expensive drugs.
    Young D
    Am J Health Syst Pharm; 2004 Aug; 61(16):1632, 1636. PubMed ID: 15540471
    [No Abstract]   [Full Text] [Related]  

  • 12. The emerging specialty pharmaceutical market segment.
    Giaquinta D
    Manag Care Interface; 2003 Apr; 16(4):35-6. PubMed ID: 12747139
    [No Abstract]   [Full Text] [Related]  

  • 13. The evolution of the regulatory framework for the plasma and plasma-derived medicinal products system in Italy.
    Calizzani G; Vaglio S; Candura F; Profili S; Lanzoni M; Cristiano K; Tamburrini MR; Grazzini G; Oleari F
    Blood Transfus; 2013 Sep; 11 Suppl 4(Suppl 4):s6-12. PubMed ID: 24333315
    [No Abstract]   [Full Text] [Related]  

  • 14. States try medication recycling programs.
    Kuehn BM
    JAMA; 2008 Jul; 300(1):28. PubMed ID: 18594030
    [No Abstract]   [Full Text] [Related]  

  • 15. Medicinal products in the European Union--between harmonization and divergence.
    Lojko N
    Med Law; 2010 Mar; 29(1):61-76. PubMed ID: 22457998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Innovative medicinal products: the new criteria of the Italian Medicines Agency.].
    Mammarella F; Tafuri G
    Recenti Prog Med; 2018 May; 109(5):261-262. PubMed ID: 29771247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicines mismatch.
    Collier J
    Lancet; 1996 Jan; 347(8996):212. PubMed ID: 8551877
    [No Abstract]   [Full Text] [Related]  

  • 18. Biotech products pose distribution challenges.
    Szeinbach SL; Gillenwater EL
    Am Pharm; 1994 Mar; NS34(3):19-20. PubMed ID: 8192094
    [No Abstract]   [Full Text] [Related]  

  • 19. Providers fuel 'gray market'. Some sell while others buy during drug shortage.
    Lee J
    Mod Healthc; 2011 Sep; 41(36):8-9. PubMed ID: 21928533
    [No Abstract]   [Full Text] [Related]  

  • 20. Provincially administered universal pharmacare programs require a secure, affordable drug supply: A matter of national security?
    McAlister VC
    Can J Surg; 2018 Aug; 61(4):220-221. PubMed ID: 30067177
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.